Latest Breaking News On - Malaria virulence - Page 1 : comparemela.com

Image: Dr Paul Gilson, Co-head Malaria Virulence and Drug Discovery Group Burnet Institute research into malaria, hepatitis, adolescent menstrual health and the impact of COVID-19 restrictions in people who use drugs will benefit from National Health and Medical Research Council (NHMRC) Ideas Grants for 2021 valued at more than AUD $3.5 million. Dr Paul Gilson has been awarded AUD $1,035,623 for the development of novel anti-malaria drugs that block parasite invasion. “Malaria is a devastating parasitic disease that kills over 400,000 people a year,” Dr Gilson, Co-head of Burnet’s Malaria Virulence and Drug Discovery Group, and Head of Burnet Cell Imaging Facility, said.

Paul gilsonHayley bullenPaul dietzePeter azzopardiNational healthHead of adolescent healthBurnet coDrug discovery groupBurnet instituteResearch councilCo head malaria virulenceDrug discoveryMedical research councilIdeas grantsMalaria virulenceBurnet cell imaging facility